EverSource Wealth Advisors LLC reduced its position in Molina Healthcare, Inc (NYSE:MOH – Free Report) by 83.0% in the 4th quarter, HoldingsChannel.com reports. The fund owned 595 shares of the company’s stock after selling 2,905 shares during the period. EverSource Wealth Advisors LLC’s holdings in Molina Healthcare were worth $103,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Torren Management LLC bought a new stake in shares of Molina Healthcare in the fourth quarter valued at about $26,000. Miller Global Investments LLC bought a new stake in shares of Molina Healthcare in the fourth quarter valued at about $27,000. Cromwell Holdings LLC raised its holdings in shares of Molina Healthcare by 211.9% in the fourth quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock valued at $32,000 after acquiring an additional 125 shares in the last quarter. Rakuten Securities Inc. raised its holdings in shares of Molina Healthcare by 5,020.0% in the fourth quarter. Rakuten Securities Inc. now owns 256 shares of the company’s stock valued at $44,000 after acquiring an additional 251 shares in the last quarter. Finally, MUFG Securities EMEA plc bought a new stake in shares of Molina Healthcare in the second quarter valued at about $48,000. 98.50% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Several research firms recently weighed in on MOH. Barclays lifted their price objective on Molina Healthcare from $161.00 to $199.00 and gave the company an “underweight” rating in a report on Tuesday, May 26th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Molina Healthcare in a report on Tuesday, April 21st. Zacks Research upgraded shares of Molina Healthcare from a “strong sell” rating to a “hold” rating in a report on Monday, April 20th. Sanford C. Bernstein reiterated an “outperform” rating on shares of Molina Healthcare in a report on Friday, March 13th. Finally, Wells Fargo & Company boosted their target price on shares of Molina Healthcare from $141.00 to $159.00 and gave the stock an “equal weight” rating in a report on Monday, April 27th. Three investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, Molina Healthcare has a consensus rating of “Hold” and an average target price of $178.53.
Molina Healthcare Stock Performance
Shares of Molina Healthcare stock opened at $182.82 on Tuesday. The firm has a market capitalization of $9.52 billion, a P/E ratio of 54.09 and a beta of 0.80. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97. The company has a 50 day moving average price of $164.58 and a 200 day moving average price of $161.21. Molina Healthcare, Inc has a 52 week low of $121.06 and a 52 week high of $311.52.
Molina Healthcare (NYSE:MOH – Get Free Report) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, beating the consensus estimate of $1.57 by $0.78. The firm had revenue of $10.80 billion during the quarter, compared to analyst estimates of $10.91 billion. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. Molina Healthcare’s revenue was down 3.1% on a year-over-year basis. During the same period last year, the firm posted $6.08 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Sell-side analysts expect that Molina Healthcare, Inc will post 5.23 EPS for the current year.
Insider Activity at Molina Healthcare
In related news, CAO Maurice Hebert sold 600 shares of the stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the transaction, the chief accounting officer directly owned 12,815 shares of the company’s stock, valued at $2,454,713.25. This trade represents a 4.47% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Jeff D. Barlow sold 17,811 shares of the stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the completion of the transaction, the insider directly owned 67,175 shares of the company’s stock, valued at $12,502,611. The trade was a 20.96% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.44% of the company’s stock.
Molina Healthcare Profile
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Read More
- Five stocks we like better than Molina Healthcare
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
